tumor
UNASSIGNED: TPS150 Background: Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) and its ligands, VEGF-C and VEGF-D, control tumor lymphangiogenesis by enhancing proliferation and survival of lymphatic endothelial cells.